Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Introduction<p>T cell receptor-engineered T cell therapy has emerged as a promising approach in cancer immunotherapy, leveraging the ability of T cells to recognize tumor antigens presented on major histocompatibility complex molecules, offering a targeted approach for treating cancers. This s...

詳細記述

保存先:
書誌詳細
第一著者: Saleh Alrhmoun (19193851) (author)
その他の著者: Roman Perik-Zavodskii (19193839) (author), Marina Fisher (19828437) (author), Julia Lopatnikova (4164058) (author), Olga Perik-Zavodskaia (19193842) (author), Julia Shevchenko (19193845) (author), Kirill Nazarov (19193854) (author), Julia Philippova (19828440) (author), Vasily Kurilin (19828443) (author), Olga Kichakova (22680860) (author), Evgenii Zavjalov (12230774) (author), Elena Golikova (472121) (author), Petr Timashev (10031740) (author), Petr Glybochko (13011754) (author), Sergey Sennikov (4164055) (author)
出版事項: 2025
主題:
Genetic Immunology
TCR-T cells
TCR-T
T cells
adoptive cell therapy
her2/neu
ErbB2
ScRNA-seq
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料